Followers | 145 |
Posts | 27561 |
Boards Moderated | 3 |
Alias Born | 02/07/2004 |
Tuesday, September 05, 2017 12:01:17 PM
JERUSALEM, September 5, 2017 /PRNewswire via COMTEX/ -- JERUSALEM, September 5, 2017 /PRNewswire/ --
IDenta Corp IDTA, +0.00% is a worldwide leader in the development of the proprietary on-site drug, precursor drug and explosive detection kits. The Company has submitted bids for major tenders in two leading European countries with high potential for success. The tenders are valued at over 2 million dollars. They emphasize quality and reliability, two areas in which IDenta excels. The company anticipates bidding for more significant tenders in the near future.
Amichai Glattstein, COO of IDenta: "We are proud to participate in these tenders and to help enhance the security of Europe and around the world. IDenta will continue to be a leader in the field of detection worldwide."
About IDenta Corp
Since 2002, IDenta Corporation and its subsidiary IDenta Ltd have been recognized as a worldwide leader in the development of the proprietary on-site Drug, Drug Precursor and Explosive detection kits. IDenta develops, manufactures and distributes revolutionary products for both the professional and civilian markets. Products consistently pass the highest qualifications and testing procedures of law enforcement and security agencies around the world.
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM